MYX — Mycelx Technologies Income Statement
0.000.00%
Last trade - 00:00- £15.96m
- £15.68m
- $11.74m
Annual income statement for Mycelx Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8.48 | 10 | 10.9 | 4.9 | 11.7 |
| Cost of Revenue | |||||
| Gross Profit | 3.27 | 4.44 | 3.89 | 1.34 | 5.62 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 9.58 | 13.6 | 14.2 | 9.46 | 11.5 |
| Operating Profit | -1.1 | -3.57 | -3.33 | -4.55 | 0.193 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.13 | -3.57 | -3.34 | -2.64 | 0.337 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.43 | -3.99 | -3.71 | -2.72 | 0.334 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.43 | -3.99 | -3.71 | -2.72 | 0.334 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.43 | -3.99 | -3.71 | -2.72 | 0.334 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.173 | -0.18 | -0.161 | -0.17 | 0.007 |